IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Intra-Cellular Therapies Inc.

Q2 2018 vs Q3 2018

Comparing institutional holders between quarters

Quarters

Q3 2018Q2 2018Q1 2018Q4 2017Q3 2017
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
General American Investors Co Inc
UNCHANGED
Shares299,942 from 299,942
Change0 (0%)
Value$6.5K (+$1.2K)
Filed 2018-10-26
Status
General American Investors Co Inc
UNCHANGED299,942299,94200%$5.3K$6.5K+$1.2K2018-10-26
Showing 1 of 1 institutions